Amgen Inc. (1AMGN)
MTA
Closed
Aug 21, 2026
Day's Range
370.2552 wk Range
230.90Overview - 1AMGN - Amgen Inc.
Key Statistics
Valuation
Enterprise Value
210.98B
P/E (Trailing)
‪27.31‬
PEG Ratio
‪0.41‬
Price / Sales (TTM)
‪5.34‬
Price / Book
‪20.36‬
EV / EBITDA
‪14.30‬
Profitability
Gross Margin
‪72.04%‬
Profit Margin
‪22.95%‬
Operating Margin
‪35.54%‬
Return on Assets
‪8.66%‬
Return on Equity
‪91.47%‬
Ownership
Shares Outstanding
541.00M
Float
539.16M
Held by Insiders
‪0.22%‬
Held by Institutions
‪85.11%‬
Price stats
Beta
‪0.41‬
50-Day Avg
‪327.63‬
200-Day Avg
‪303.55‬
Dividends
Payout Ratio
‪60.87%‬
Frequency
Semi-Annual
Market Cap - 1AMGN - Amgen Inc.
Peers - 1AMGN - Amgen Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on MTA.
- 1AMGNMTAAmgen Inc.155.67BMarket Cap+34.30%52-week change27.31P/E (Trailing)‪22.95%‬Profit Margin
- 1LLYMTAEli Lilly and Company853.56BMarket Cap+44.62%52-week change42.34P/E (Trailing)‪33.52%‬Profit Margin
- 1JNJMTAJohnson & Johnson428.46BMarket Cap+35.82%52-week change31.30P/E (Trailing)‪21.48%‬Profit Margin
- 1ABBVMTAAbbVie Inc.344.57BMarket Cap+21.59%52-week change74.43P/E (Trailing)‪9.80%‬Profit Margin
- 1ROMTARoche Holding AG294.63BMarket Cap+26.89%52-week change24.52P/E (Trailing)‪19.60%‬Profit Margin
- 1MRKXMTAMerck & Co., Inc.240.41BMarket Cap+44.15%52-week change125.16P/E (Trailing)‪4.76%‬Profit Margin
- 1NOVNMTANovartis AG238.75BMarket Cap+22.16%52-week change24.02P/E (Trailing)‪22.50%‬Profit Margin
Profile Summary - 1AMGN - Amgen Inc.
About
Amgen Inc. is a leading biotechnology company that discovers, develops, manufactures, and delivers human therapeutics worldwide. Its principal products target serious illnesses, including Enbrel for rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for plaque psoriasis, psoriatic arthritis, and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
